» Articles » PMID: 20160609

Fluid Resuscitation: Past, Present, and the Future

Overview
Journal Shock
Date 2010 Feb 18
PMID 20160609
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Hemorrhage remains a major cause of preventable death following both civilian and military trauma. The goals of resuscitation in the face of hemorrhagic shock are restoring end-organ perfusion and maintaining tissue oxygenation while attempting definitive control of bleeding. However, if not performed properly, resuscitation can actually exacerbate cellular injury caused by hemorrhagic shock, and the type of fluid used for resuscitation plays an important role in this injury pattern. This article reviews the historical development and scientific underpinnings of modern resuscitation techniques. We summarized data from a number of studies to illustrate the differential effects of commonly used resuscitation fluids, including isotonic crystalloids, natural and artificial colloids, hypertonic and hyperoncotic solutions, and artificial oxygen carriers, on cellular injury and how these relate to clinical practice. The data reveal that a uniformly safe, effective, and practical resuscitation fluid when blood products are unavailable and direct hemorrhage control is delayed has been elusive. Yet, it is logical to prevent this cellular injury through wiser resuscitation strategies than attempting immunomodulation after the damage has already occurred. Thus, we describe how some novel resuscitation strategies aimed at preventing or ameliorating cellular injury may become clinically available in the future.

Citing Articles

Editorial: Fluid Therapy in Animals: Physiologic Principles and Contemporary Fluid Resuscitation Considerations.

Muir W, Hughes D, Silverstein D Front Vet Sci. 2021; 8:744080.

PMID: 34746284 PMC: 8563835. DOI: 10.3389/fvets.2021.744080.


Traumatic Brain Injury-A Review of Intravenous Fluid Therapy.

Pigott A, Rudloff E Front Vet Sci. 2021; 8:643800.

PMID: 34307515 PMC: 8299062. DOI: 10.3389/fvets.2021.643800.


Shen-fu injection alleviates acute renal injury by reducing cytokine levels and modulating apoptosis in a porcine hemorrhagic shock model.

Yuan W, Wu J, Zhang Q, Liang Y, Zhang M, Qin H Acta Cir Bras. 2021; 36(4):e360405.

PMID: 34076082 PMC: 8184256. DOI: 10.1590/ACB360405.


A Multicentric, Randomized, Controlled Phase III Study of Centhaquine (Lyfaquin) as a Resuscitative Agent in Hypovolemic Shock Patients.

Gulati A, Choudhuri R, Gupta A, Singh S, Ali S, Sidhu G Drugs. 2021; 81(9):1079-1100.

PMID: 34061314 PMC: 8167383. DOI: 10.1007/s40265-021-01547-5.


Prehospital Damage Control: The Management of Volume, Temperature… and Bleeding!.

Melendez-Lugo J, Caicedo Y, Guzman-Rodriguez M, Serna J, Ordonez J, Angamarca E Colomb Med (Cali). 2021; 51(4):e4024486.

PMID: 33795898 PMC: 7968431. DOI: 10.25100/cm.v51i4.4486.


References
1.
Kauvar D, Holcomb J, Norris G, Hess J . Fresh whole blood transfusion: a controversial military practice. J Trauma. 2006; 61(1):181-4. DOI: 10.1097/01.ta.0000222671.84335.64. View

2.
Xiao N, Wang X, Diao Y, Liu R, Tian K . Effect of initial fluid resuscitation on subsequent treatment in uncontrolled hemorrhagic shock in rats. Shock. 2004; 21(3):276-80. DOI: 10.1097/01.shk.0000110622.42625.cb. View

3.
Krausz M, Bashenko Y, Hirsh M . Crystalloid or colloid resuscitation of uncontrolled hemorrhagic shock after moderate splenic injury. Shock. 2000; 13(3):230-5. DOI: 10.1097/00024382-200003000-00010. View

4.
Rice J, Philbin N, McGwin G, Arnaud F, Johnson T, Flournoy W . Bovine polymerized hemoglobin versus Hextend resuscitation in a swine model of severe controlled hemorrhagic shock with delay to definitive care. Shock. 2006; 26(3):302-10. DOI: 10.1097/01.shk.0000226338.48033.c2. View

5.
Sauaia A, Moore F, Moore E, Moser K, Brennan R, Read R . Epidemiology of trauma deaths: a reassessment. J Trauma. 1995; 38(2):185-93. DOI: 10.1097/00005373-199502000-00006. View